Literature DB >> 22396595

The mevalonate pathway regulates microRNA activity in Caenorhabditis elegans.

Zhen Shi1, Gary Ruvkun.   

Abstract

The mevalonate pathway is highly conserved and mediates the production of isoprenoids, which feed into biosynthetic pathways for sterols, dolichol, ubiquinone, heme, isopentenyl adenine, and prenylated proteins. We found that in Caenorhabditis elegans, the nonsterol biosynthetic outputs of the mevalonate pathway are required for the activity of microRNAs (miRNAs) in silencing their target mRNAs. Inactivation of genes that mediate multiple steps of the mevalonate pathway causes derepression of several miRNA target genes, with no disruption of the miRNA levels, suggesting a role in miRNA-induced silencing complex activity. Dolichol phosphate, synthesized from the mevalonate pathway, functions as a lipid carrier of the oligosaccharide moiety destined for protein N-linked glycosylation. Inhibition of the dolichol pathway of protein N-glycosylation also causes derepression of miRNA target mRNAs. The proteins that mediate miRNA repression are therefore likely to be regulated by N-glycosylation. Conversely, drugs such as statins, which inhibit the mevalonate pathway, may compromise miRNA repression as well as the more commonly considered cholesterol biosynthesis.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22396595      PMCID: PMC3311396          DOI: 10.1073/pnas.1202421109

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  37 in total

1.  Axon guidance genes identified in a large-scale RNAi screen using the RNAi-hypersensitive Caenorhabditis elegans strain nre-1(hd20) lin-15b(hd126).

Authors:  Caroline Schmitz; Parag Kinge; Harald Hutter
Journal:  Proc Natl Acad Sci U S A       Date:  2007-01-09       Impact factor: 11.205

2.  Different anti-HCV profiles of statins and their potential for combination therapy with interferon.

Authors:  Masanori Ikeda; Ken-ichi Abe; Masashi Yamada; Hiromichi Dansako; Kazuhito Naka; Nobuyuki Kato
Journal:  Hepatology       Date:  2006-07       Impact factor: 17.425

3.  A whole-genome RNAi Screen for C. elegans miRNA pathway genes.

Authors:  Devin H Parry; Jinling Xu; Gary Ruvkun
Journal:  Curr Biol       Date:  2007-11-20       Impact factor: 10.834

Review 4.  A parsimonious model for gene regulation by miRNAs.

Authors:  Sergej Djuranovic; Ali Nahvi; Rachel Green
Journal:  Science       Date:  2011-02-04       Impact factor: 47.728

5.  Therapeutic silencing of microRNA-122 in primates with chronic hepatitis C virus infection.

Authors:  Robert E Lanford; Elisabeth S Hildebrandt-Eriksen; Andreas Petri; Robert Persson; Morten Lindow; Martin E Munk; Sakari Kauppinen; Henrik Ørum
Journal:  Science       Date:  2009-12-03       Impact factor: 47.728

6.  nhl-2 Modulates microRNA activity in Caenorhabditis elegans.

Authors:  Christopher M Hammell; Isabella Lubin; Peter R Boag; T Keith Blackwell; Victor Ambros
Journal:  Cell       Date:  2009-03-06       Impact factor: 41.582

7.  Statins inhibit protein lipidation and induce the unfolded protein response in the non-sterol producing nematode Caenorhabditis elegans.

Authors:  Catarina Mörck; Louise Olsen; Caroline Kurth; Annelie Persson; Nadia Jin Storm; Emma Svensson; John-Olov Jansson; Marika Hellqvist; Annika Enejder; Nils J Faergeman; Marc Pilon
Journal:  Proc Natl Acad Sci U S A       Date:  2009-10-13       Impact factor: 11.205

8.  Multivesicular bodies associate with components of miRNA effector complexes and modulate miRNA activity.

Authors:  Derrick J Gibbings; Constance Ciaudo; Mathieu Erhardt; Olivier Voinnet
Journal:  Nat Cell Biol       Date:  2009-08-16       Impact factor: 28.824

9.  miR-122 activates hepatitis C virus translation by a specialized mechanism requiring particular RNA components.

Authors:  Ashley P E Roberts; Andrew P Lewis; Catherine L Jopling
Journal:  Nucleic Acids Res       Date:  2011-06-07       Impact factor: 16.971

10.  Silencing by small RNAs is linked to endosomal trafficking.

Authors:  Young Sik Lee; Sigal Pressman; Arlise P Andress; Kevin Kim; Jamie L White; Justin J Cassidy; Xin Li; Kim Lubell; Do Hwan Lim; Ik Sang Cho; Kenji Nakahara; Jonathan B Preall; Priya Bellare; Erik J Sontheimer; Richard W Carthew
Journal:  Nat Cell Biol       Date:  2009-08-16       Impact factor: 28.824

View more
  19 in total

Review 1.  Biogenesis, turnover, and mode of action of plant microRNAs.

Authors:  Kestrel Rogers; Xuemei Chen
Journal:  Plant Cell       Date:  2013-07-23       Impact factor: 11.277

2.  Trip to ER: MicroRNA-mediated translational repression in plants.

Authors:  Xuan Ma; Xiaofeng Cao; Beixin Mo; Xuemei Chen
Journal:  RNA Biol       Date:  2013-09-10       Impact factor: 4.652

Review 3.  Neurological aspects of human glycosylation disorders.

Authors:  Hudson H Freeze; Erik A Eklund; Bobby G Ng; Marc C Patterson
Journal:  Annu Rev Neurosci       Date:  2015-04-02       Impact factor: 12.449

4.  MicroRNA and autophagy--C. elegans joins the crew.

Authors:  Olivier Voinnet
Journal:  EMBO Rep       Date:  2013-05-17       Impact factor: 8.807

5.  The UPRmt Protects Caenorhabditis elegans from Mitochondrial Dysfunction by Upregulating Specific Enzymes of the Mevalonate Pathway.

Authors:  Olga Oks; Shany Lewin; Irina Langier Goncalves; Amir Sapir
Journal:  Genetics       Date:  2018-03-29       Impact factor: 4.562

6.  Controlled sumoylation of the mevalonate pathway enzyme HMGS-1 regulates metabolism during aging.

Authors:  Amir Sapir; Assaf Tsur; Thijs Koorman; Kaitlin Ching; Prashant Mishra; Annabelle Bardenheier; Lisa Podolsky; Ulrike Bening-Abu-Shach; Mike Boxem; Tsui-Fen Chou; Limor Broday; Paul W Sternberg
Journal:  Proc Natl Acad Sci U S A       Date:  2014-09-03       Impact factor: 11.205

Review 7.  The Whereabouts of microRNA Actions: Cytoplasm and Beyond.

Authors:  Anthony K L Leung
Journal:  Trends Cell Biol       Date:  2015-10       Impact factor: 20.808

Review 8.  Lipid and Carbohydrate Metabolism in Caenorhabditis elegans.

Authors:  Jennifer L Watts; Michael Ristow
Journal:  Genetics       Date:  2017-10       Impact factor: 4.562

9.  Recent Molecular Genetic Explorations of Caenorhabditis elegans MicroRNAs.

Authors:  Victor Ambros; Gary Ruvkun
Journal:  Genetics       Date:  2018-07       Impact factor: 4.562

Review 10.  Cholesterol Metabolic Reprogramming in Cancer and Its Pharmacological Modulation as Therapeutic Strategy.

Authors:  Isabella Giacomini; Federico Gianfanti; Maria Andrea Desbats; Genny Orso; Massimiliano Berretta; Tommaso Prayer-Galetti; Eugenio Ragazzi; Veronica Cocetta
Journal:  Front Oncol       Date:  2021-05-24       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.